SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unitedhealth Group Inc – ‘10-K’ for 12/31/11 – ‘EX-31.1’

On:  Wednesday, 2/8/12, at 7:46pm ET   ·   As of:  2/9/12   ·   For:  12/31/11   ·   Accession #:  731766-12-9   ·   File #:  1-10864

Previous ‘10-K’:  ‘10-K’ on 2/10/11 for 12/31/10   ·   Next:  ‘10-K’ on 2/7/13 for 12/31/12   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/09/12  Unitedhealth Group Inc            10-K       12/31/11   99:21M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.44M 
 3: EX-21.1     Subsidiaries of the Company                         HTML    196K 
 4: EX-23.1     Consent of Independent Registered Public            HTML     32K 
                Accounting Firm                                                  
 5: EX-24.1     Power of Attorney                                   HTML     38K 
 2: EX-12.1     Computation of Ratio of Earnings to Fixed Charges   HTML     43K 
 6: EX-31.1     Certification Pursuant to Section 302 of the        HTML     46K 
                Sarbanes-Oxley Act 2002                                          
 7: EX-32.1     Certification Pursuant to Section 906 of the        HTML     35K 
                Sarbanes-Oxley Act 2002                                          
67: R1          Document and Entity Information                     HTML     59K 
54: R2          Condensed Consolidated Balance Sheets               HTML    157K 
65: R3          Consolidated Balance Sheets (Parenthetical)         HTML     66K 
70: R4          Condensed Consolidated Statements of Operations     HTML    122K 
89: R5          Condensed Consolidated Statements of Changes in     HTML    112K 
                Shareholders' Equity                                             
56: R6          Consolidated Statement of Changes in Shareholders   HTML     36K 
                equity (Parentheticals)                                          
64: R7          Condensed Consolidated Statements of Cash Flows     HTML    169K 
48: R8          Description of Business                             HTML     34K 
38: R9          Basis of Presentation                               HTML    112K 
90: R10         Investments                                         HTML    276K 
72: R11         Fair Value                                          HTML    305K 
71: R12         Property, Equipment and Capitalized Software        HTML     55K 
77: R13         Goodwill                                            HTML    123K 
78: R14         Medical Costs and Medical Costs Payable             HTML     62K 
75: R15         Commercial Paper and Long-Term Debt                 HTML    174K 
79: R16         Income Taxes                                        HTML    148K 
66: R17         Shareholders' Equity                                HTML     61K 
68: R18         Share-Based Compensation                            HTML     97K 
74: R19         Commitments and Contingencies                       HTML     66K 
99: R20         Segment Financial Information                       HTML    301K 
85: R21         Quarterly Financial Data (Unaudited)                HTML     76K 
60: R22         Schedule I                                          HTML    175K 
73: R23         Basis of Presentation (Policy)                      HTML    203K 
62: R24         Basis of Presentation Basis of Presentation         HTML     49K 
                (Tables)                                                         
29: R25         Investments (Tables)                                HTML    273K 
86: R26         Fair Value (Tables)                                 HTML    295K 
94: R27         Property, Equipment and Capitalized Software        HTML     52K 
                (Tables)                                                         
43: R28         Goodwill (Tables)                                   HTML    127K 
42: R29         Medical Costs and Medical Costs Payable Medical     HTML     59K 
                Costs And Medical Costs Payable (Tables)                         
46: R30         Commercial Paper and Long-Term Debt (Tables)        HTML    175K 
47: R31         Income Taxes Income Taxes (Tables)                  HTML    147K 
49: R32         Shareholders' Equity (Tables)                       HTML     39K 
21: R33         Share-Based Compensation (Tables)                   HTML     79K 
83: R34         Commitments and Contingencies Commitments and       HTML     42K 
                Contingencies (Tables)                                           
58: R35         Segment Financial Information (Tables)              HTML    289K 
61: R36         Quarterly Financial Data (Unaudited) Quarterly      HTML     74K 
                Financial Data (Tables)                                          
33: R37         Basis of Presentation Basis of Presentation         HTML     64K 
                (Details)                                                        
98: R38         Basis of Presentation Medicare Part D (Details)     HTML     35K 
14: R39         Basis of Presentation Useful lives for property,    HTML     35K 
                equipment and capitalized software (Details)                     
51: R40         Investments (Narrative) (Details)                   HTML     43K 
88: R41         Investments (Short-Term and Long-Term Investments)  HTML     89K 
                (Details)                                                        
31: R42         Investments (Fair Value of Mortgage-Backed          HTML     51K 
                Securities by Credit Rating Origination) (Details)               
41: R43         Investments (Amortized Cost and Fair Value of       HTML     77K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
45: R44         Investments (Amortized Cost and Fair Value of       HTML     63K 
                Held-To-Maturity Debt Securities by Contractual                  
                Maturity) (Details)                                              
55: R45         Investments (Fair Value of Available-For-Sale       HTML     64K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
20: R46         Investments (Net Realized Gains) (Details)          HTML     52K 
37: R47         Fair Value (Narrative) (Details)                    HTML     49K 
16: R48         Fair Value (Financial Assets and Liabilities,       HTML     74K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
87: R49         Fair Value (Assets and Liabilities measured at      HTML     86K 
                fair value on a recurring basis) (Details)                       
30: R50         Fair Value (Summary of Fair Value and Carrying      HTML     74K 
                Value for Certain Financial Instruments for Which                
                it is Practicable to Estimate Fair Value)                        
                (Details)                                                        
84: R51         Fair Value (Reconciliation of Assets Measured at    HTML     56K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
34: R52         Property, Equipment and Capitalized Software        HTML     36K 
                Property, Equipment and Capitalized Software                     
                (Narrative) (Details)                                            
52: R53         Property, Equipment and Capitalized Software        HTML     60K 
                Property, Equipment and Capitalized Software table               
                (Details)                                                        
15: R54         Goodwill and Other Intangible Assets Numbers in     HTML     39K 
                narrative (Details)                                              
18: R55         Goodwill (Changes in the Carrying Amount of         HTML     67K 
                Goodwill by Reporting Segment) (Details)                         
44: R56         Goodwill and Other Intangible Assets Gross          HTML     44K 
                carrying value, accumulated amortization and net                 
                carrying value of ther intangible assets (Details)               
24: R57         Goodwill and Other Intangible Assets                HTML     41K 
                Weighted-average useful lives assigned to                        
                finite-lived intangible assets acquired in                       
                business combinations (Details)                                  
91: R58         Goodwill and Other Intangible Assets Amortization   HTML     42K 
                Expense relating to Intangible Assets (Details)                  
57: R59         Medical Costs and Medical Costs Payable Narrative   HTML     32K 
                (Details)                                                        
76: R60         Medical Costs and Medical Costs Payable Medical     HTML     58K 
                Costs And Medical Costs Payable (Details)                        
36: R61         Commercial Paper and Long-Term Debt (Narrative)     HTML     49K 
                (Details)                                                        
39: R62         Commercial Paper and Long-Term Debt (Commercial     HTML     79K 
                Paper and Long-Term Debt) (Details)                              
82: R63         Commercial Paper and Long-Term Debt Maturities of   HTML     49K 
                commercial paper and long-term debt (Details)                    
80: R64         Commercial Paper and Long-Term Debt (Summary of     HTML     42K 
                Effect of Changes in Fair Value of Fair Value                    
                Hedges) (Details)                                                
59: R65         Income Taxes Income Tax Narrative (Details)         HTML     46K 
81: R66         Income Taxes Components of the provision for        HTML     54K 
                income taxes (Details)                                           
35: R67         Income Taxes Reconciliation of the tax provision    HTML     76K 
                at the U.S. Federal Statutory Rate to the                        
                provision for income taxes (Details)                             
63: R68         Income Taxes Components of deferred income tax      HTML     98K 
                assets and liabilities (Details)                                 
93: R69         Income Taxes Reconciliation of the beginning and    HTML     50K 
                ending amount of unrecognized tax benefits                       
                (Details)                                                        
17: R70         Shareholders' Equity (Details)                      HTML     81K 
28: R71         Share-Based Compensation (Narrative) (Details)      HTML     82K 
53: R72         Share-Based Compensation (Stock Option and SAR      HTML     80K 
                Activity) (Details)                                              
23: R73         Share-Based Compensation (Share-Based Compensation  HTML     49K 
                Principal Fair Value Assumptions) (Details)                      
97: R74         Share-Based Compensation (Restricted Share          HTML     59K 
                Activity) (Details)                                              
32: R75         Commitments and Contingencies (Details)             HTML     51K 
25: R76         Commitments and Contingencies Future lease          HTML     52K 
                payments (Details)                                               
27: R77         Segment Financial Information (Narrative)           HTML     32K 
                (Details)                                                        
19: R78         Segment Financial Information (Details)             HTML    143K 
22: R79         Quarterly Financial Data (Unaudited) Quarterly      HTML     58K 
                Financial Data (Details)                                         
69: R80         Schedule I Schedule I Condensed Balance Sheet       HTML    154K 
                (Details)                                                        
26: R81         Schedule I Condensed Statements of Operations       HTML     79K 
                (Details)                                                        
92: R82         Schedule I Schedule I Condensed Statements of Cash  HTML    111K 
                Flows (Details)                                                  
50: R83         Schedule I Numbers in Narrative (Details)           HTML     33K 
95: XML         IDEA XML File -- Filing Summary                      XML    156K 
40: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   3.65M 
 8: EX-101.INS  XBRL Instance -- unh-20111231                        XML   5.58M 
10: EX-101.CAL  XBRL Calculations -- unh-20111231_cal                XML    318K 
11: EX-101.DEF  XBRL Definitions -- unh-20111231_def                 XML   1.05M 
12: EX-101.LAB  XBRL Labels -- unh-20111231_lab                      XML   2.20M 
13: EX-101.PRE  XBRL Presentations -- unh-20111231_pre               XML   1.40M 
 9: EX-101.SCH  XBRL Schema -- unh-20111231                          XSD    241K 
96: ZIP         XBRL Zipped Folder -- 0000731766-12-000009-xbrl      Zip    397K 


‘EX-31.1’   —   Certification Pursuant to Section 302 of the Sarbanes-Oxley Act 2002


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  UNH EX 31.1 2011 10K  


EXHIBIT 31.1
CERTIFICATIONS PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
Certification of Principal Executive Officer

I, Stephen J. Hemsley, certify that:
1.
I have reviewed this Annual Report on Form 10-K of UnitedHealth Group Incorporated (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
President and Chief Executive Officer
 
 






Certification of Principal Financial Officer

I, David S. Wichmann, certify that:
1.
I have reviewed this Annual Report on Form 10-K of UnitedHealth Group Incorporated (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
/s/    DAVID S. WICHMANN
 
David S. Wichmann
Executive Vice President and
Chief Financial Officer of UnitedHealth Group and
President of UnitedHealth Group Operations




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed as of:2/9/124
Filed on:2/8/12SC 13G/A
For Period end:12/31/115
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/14/12  SEC                               UPLOAD10/06/17    1:34K  Unitedhealth Group Inc.
 4/25/12  SEC                               UPLOAD10/06/17    1:60K  Unitedhealth Group Inc.
Top
Filing Submission 0000731766-12-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 12:06:02.1pm ET